<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112631">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01908166</url>
  </required_header>
  <id_info>
    <org_study_id>VAR0099</org_study_id>
    <secondary_id>NCI-2013-01353</secondary_id>
    <secondary_id>P30CA124435</secondary_id>
    <nct_id>NCT01908166</nct_id>
  </id_info>
  <brief_title>Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions</brief_title>
  <official_title>US Elastography for Characterizing Focal Lesions in the Liver and Kidney</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial studies ultrasound elastography in diagnosing patients with kidney or
      liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may
      be a less invasive way to check for kidney or liver solid focal lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. To determine the utility of ultrasound elastography in correlation with kidney or liver
      biopsy or magnetic resonance imaging (MRI) or computed tomography (CT) results.

      OUTLINE:

      Patients undergo ultrasound elastography.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Strain ratio for all lesions measured by comparing the lesion to the adjacent normal tissue</measure>
    <time_frame>Up to 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Suspicious liver and kidney lesions will be analyzed separately on a per-lesion basis. Within each population, the strain ratio of cases and controls will be compared using the Wilcoxon rank sum test, and the analysis will be illustrated using the non-parametric receiver operating characteristic (ROC).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Adult Primary Liver Cancer</condition>
  <condition>Kidney Tumor</condition>
  <arm_group>
    <arm_group_label>Diagnostic (ultrasound elastography)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo ultrasound elastography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound elasticity imaging</intervention_name>
    <description>Undergo ultrasound elastography</description>
    <arm_group_label>Diagnostic (ultrasound elastography)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  There are no restrictions on life expectancy

          -  Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be
             employed

          -  Patients of any ethnic background

          -  Ability to understand and the willingness to sign a written informed consent document

        Exclusion Criteria:

          -  Patients should not be taking other investigational agents

          -  No requirements due to co-morbid disease or intercurrent illness, as needed

          -  No restrictions on allergic reactions as no imaging agent will be used

          -  Concomitant medications for treatment of the target lesion

          -  Pregnant or nursing patients will be excluded from the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juergen Willmann</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University Hospitals and Clinics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University Hospitals and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Euodia</last_name>
      <phone>650-723-7419</phone>
      <email>euodia@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Juergen K. Willmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 23, 2014</lastchanged_date>
  <firstreceived_date>July 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
